ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $395,000 | +758.7% | 65,585 | +412.4% | 0.01% | +500.0% |
| Q3 2019 | $46,000 | -37.8% | 12,800 | -53.3% | 0.00% | 0.0% |
| Q2 2019 | $74,000 | -23.7% | 27,430 | +3.9% | 0.00% | -50.0% |
| Q3 2018 | $97,000 | +142.5% | 26,400 | +90.4% | 0.00% | +100.0% |
| Q4 2017 | $40,000 | -34.4% | 13,865 | +5.0% | 0.00% | 0.0% |
| Q2 2017 | $61,000 | -81.3% | 13,200 | -60.1% | 0.00% | -88.9% |
| Q1 2015 | $326,000 | – | 33,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |